InnoCan Pharma Submits New Patent Applications for Advanced Pain Relief Technology
The Patent Application is in line with Innocan’s Strategy to Expand the Scope of its Combined Magnesium and Cannabis Topical Solution HERZLIYA, Israel and CALGARY, AB, June 12, 2023 /PRNewswire/ — InnoCan Pharma Corporation (CSE:INNO) (“Innocan Pharma” or the “Company”), a pharmaceutical technology company leveraging its novel cannabis-based therapeutics portfolio of targeted healing products, has announced the … Read more